Meeting
2017 ASCO Annual Meeting
Evaluating the repertoire of immune checkpoint markers expressed on peripheral and ascites CD8+ T cells in ovarian cancer.
Authors
Stephanie Gaillard
Duke Cancer Institute, Duke University Medical Center, Durham, NC
Stephanie Gaillard , Chelsae Dumbauld , Alyssa Bilewski , Jessie A Ehrisman , Angeles Alvarez Secord , Laura Jean Havrilesky , Andrew Berchuck , Kent Weinhold , Cliburn Chan , John Yi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5571)
DOI
10.1200/JCO.2017.35.15_suppl.5571
Abstract #
5571
Poster Bd #
393
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita
Poster
2020 Gastrointestinal Cancers Symposium
ARID1A mutation to define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer.
First Author: Amir Mehrvarz Sarshekeh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
PD1 and CD39 expression on tumor infiltrating lymphocytes in patients with gastric cancer.
First Author: Takafumi Okayama